On the long acting gastric antisecretory activity of LM 24056 a non H2 antagonist.
LM 24056, a phenothiazine derivative with no central effects, can be classified as a non anti H2 antisecretory agent with a long duration of action. Its activity was demonstrated orally at low dose in pentagastrin stimulated Shay rat and in Heidenhain pouch in dog against gastrin, pentagastrin, carbachol and test meal. LM 24056 possesses very weak affinity to muscarinic receptors in vitro and in vivo. It has negligible anticholinergic properties in rats and mice at the peripheral level but no effect at the central level. The long lasting antisecretory action of LM 24056 may be supported by the persistent presence in plasma of a desmethyl metabolite at higher concentrations than that of LM 24056 at any time. Contrary to LM 24056 sulfoxide and LM 24056 sulfone, desmethyl LM 24056 is a more potent antisecretory drug than LM 24056. Desmethyl LM 24056 possesses more marked affinity to peripheral muscarinic receptor than LM 24056. As the administration of therapeutic doses of LM 24056 was not followed by anticholinergic side-effects, it may be suggested that LM 24056 activity is related to a "prodrug like effect". Finally the activity of LM 24056 may be related to LM 24056 itself and/or a desmethyl metabolite.
D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D004285:Dogs; D005260:Female; D005502:Food; D005744:Gastric Acid / Q000378:metabolism*; D005755:Gastrins / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D007700:Kinetics; D051379:Mice; D010418:Pentagastrin / Q000494:pharmacology; D010640:Phenothiazines / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D011976:Receptors, Muscarinic / Q000378:metabolism; D013270:Stomach / Q000187:drug effects / Q000502:physiology
D005755:Gastrins; D010640:Phenothiazines; D011976:Receptors, Muscarinic; C028720:LM 24056; D006632:Histamine; C036084:desmethyl LM 24056; D002217:Carbachol; D010418:Pentagastrin